Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) (Q87420060)
Jump to navigation
Jump to search
scientific article published on 09 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) |
scientific article published on 09 October 2012 |
Statements
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) (English)
Johan Maertens
Harry C Schouten
Gert J Ossenkoppele
Georg Stussi
Kees van Montfort
Bart J Biemond
Dimitri Breems
August Ferrant
Carlos Graux
Georgine E de Greef
C J M Halkes
Mels Hoogendoorn
Rene M Hollestein
Mojca Jongen-Lavrencic
Mark D Levin
Arjan A van de Loosdrecht
Marinus van Marwijk Kooij
Yvette van Norden
Thomas Pabst
Edo Vellenga
Gregor E G Verhoef
Okke de Weerdt
Pierre Wijermans